5C1Z | Ligase | date | Jun 15, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Parkin (Ublr0rbr) | ||||||||||||||
authors | A.Kumar, J.D.Aguirre, T.E.C.Condos, R.J.Martinez-Torres, V.K.Cha R.Toth, R.Sundaramoorthy, P.Mercier, A.Knebel, D.E.Spratt, K.R.B G.S.Shaw, H.Walden | ||||||||||||||
compound | source | ||||||||||||||
Molecule: E3 Ubiquitin-Protein Ligase Parkin Chain: A, B Synonym: Parkin,Parkinson Juvenile Disease Protein 2,Parkin Disease Protein 2; Ec: 6.3.2.- Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Park2, Prkn Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.79 Å | ||||||||||||
ligand | CL, GOL, SO4, ZN | enzyme | Ligase E.C.6.3.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis., Kumar A, Aguirre JD, Condos TE, Martinez-Torres RJ, Chaugule VK, Toth R, Sundaramoorthy R, Mercier P, Knebel A, Spratt DE, Barber KR, Shaw GS, Walden H, EMBO J. 2015 Aug 7. pii: e201592337. PMID:26254304 |
Data retrieval |
View 5C1Z in 3D |
Visual 3D analysis of 5C1Z |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5C1Z |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |